Jazz Pharmaceuticals Plc (JAZZ)
245.51
+1.80
(+0.74%)
USD |
NASDAQ |
Sep 02, 16:00
245.51
0.00 (0.00%)
After-Hours: 17:53
Jazz Pharmaceuticals Cash and Short Term Investments (Quarterly) : 2.200B for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.200B |
| March 31, 2026 | 2.874B |
| December 31, 2025 | 2.442B |
| September 30, 2025 | 2.046B |
| June 30, 2025 | 1.670B |
| March 31, 2025 | 2.572B |
| December 31, 2024 | 2.993B |
| September 30, 2024 | 2.618B |
| June 30, 2024 | 1.981B |
| March 31, 2024 | 1.818B |
| December 31, 2023 | 1.626B |
| September 30, 2023 | 1.586B |
| June 30, 2023 | 1.362B |
| March 31, 2023 | 1.168B |
| December 31, 2022 | 881.48M |
| September 30, 2022 | 899.36M |
| June 30, 2022 | 771.26M |
| March 31, 2022 | 490.84M |
| December 31, 2021 | 591.45M |
| September 30, 2021 | 671.78M |
| June 30, 2021 | 891.40M |
| March 31, 2021 | 2.433B |
| December 31, 2020 | 2.133B |
| September 30, 2020 | 1.917B |
| June 30, 2020 | 1.696B |
| Date | Value |
|---|---|
| March 31, 2020 | 981.60M |
| December 31, 2019 | 1.077B |
| September 30, 2019 | 1.070B |
| June 30, 2019 | 882.74M |
| March 31, 2019 | 832.47M |
| December 31, 2018 | 824.62M |
| September 30, 2018 | 1.066B |
| June 30, 2018 | 816.66M |
| March 31, 2018 | 709.78M |
| December 31, 2017 | 616.53M |
| September 30, 2017 | 464.74M |
| June 30, 2017 | 328.20M |
| March 31, 2017 | 407.48M |
| December 31, 2016 | 425.96M |
| September 30, 2016 | 425.98M |
| June 30, 2016 | 916.38M |
| March 31, 2016 | 980.54M |
| December 31, 2015 | 988.78M |
| September 30, 2015 | 998.86M |
| June 30, 2015 | 921.64M |
| March 31, 2015 | 782.60M |
| December 31, 2014 | 684.04M |
| September 30, 2014 | 575.04M |
| June 30, 2014 | 268.26M |
| March 31, 2014 | 251.38M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Avadel Pharmaceuticals Plc | 91.58M |
| Perrigo Co. Plc | 399.70M |
| GH Research Plc | 362.65M |
| Cosmo NV | -- |
| Axsome Therapeutics, Inc. | 319.85M |